Cannabinoid-2 receptor activation ameliorates hepatorenal syndrome

Eszter Trojnar , Katalin Erdelyi , Csaba Matyas , Suxian Zhao
Free Radical Biology and Medicine 152 540 -550

2
2020
Interplay of Liver-Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy.

Csaba Matyas , Katalin Erdelyi , Eszter Trojnar , Suxian Zhao
Hepatology 71 ( 4) 1391 -1407

14
2020
Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Csaba Matyas , György Haskó , Lucas Liaudet , Eszter Trojnar
Nature Reviews Cardiology 18 ( 2) 117 -135

38
2021
Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.

Eszter Trojnar , Mihály Józsi , Zsóka Szabó , Marienn Réti
Frontiers in Immunology 10 240 -240

1
2019
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice

Xiaogang Xiang , Dechun Feng , Seonghwan Hwang , Tianyi Ren
Journal of Hepatology 72 ( 4) 736 -745

87
2020
Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis.

Yong He , Robim M. Rodrigues , Xiaolin Wang , Wonhyo Seo
Journal of Clinical Investigation 131 ( 3)

49
2021
Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a In Vivo and In Vitro.

Courtney D. Petro , Eszter Trojnar , James Sinclair , Zhi-Mei Liu
Infection and Immunity 87 ( 4)

10
2019
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease

Ji Soo Lee , Partha Mukhopadhyay , Csaba Matyas , Eszter Trojnar
Scientific Reports 9 ( 1) 1 -16

28
2019
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming of impaired regeneration pathways

Xiaogang Xiang , Dechun Feng , Seonghwan Hwang , Tianyi Ren
Smpte Journal

PCSK9, a promising novel target for age-related cardiovascular dysfunction

Csaba Matyas , Eszter Trojnar , Suxian Zhao , Muhammad Arif
Basic to Translational Science 8 ( 10) 1334 -1353

5
2023
Data-driven transcriptomics analysis identifies PCSK9 as a novel key regulator in liver aging

Muhammad Arif , Csaba Matyas , Partha Mukhopadhyay , Burhan Yokus
GeroScience 45 ( 5) 3059 -3077

3
2023
PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury

Josephin Wagner , Lauren M Park , Partha Mukhopadhyay , Csaba Matyas
Brain, Behavior, and Immunity 119 494 -506

2024
PCSK9 and the Liver-Brain Axis: A Novel Therapeutic Target for Alcohol Use Disorder

Jisoo Lee , Partha Mukhopadhyay , Csaba Matyas , Eszter Trojnar
NEUROPSYCHOPHARMACOLOGY 44 ( SUPPL 1) 530 -530

2019
WHOLE EXOME SEQUENCING IN ATYPICAL HEMOLYTIC UREMIC SYNDROME AND GLOMERULOPATHY

Dorottya Csuka , Nora Garam , Nora Veszeli , Eszter Trojnar
MOLECULAR IMMUNOLOGY 114 471 -471

2019
Whole exome sequencing in diagnostics of atypical hemolytic uremic syndrome

Aino R Koskinen , Eszter Trojnar , Dorottya Csuka , Rigbe Weldatsadik
Molecular Immunology 89 148 -149

2017
B cell epitope analysis of factor H autoantibodies in autoimmune haemolytic uremic syndrome

Eszter Trojnar , Katalin Uray , Sakari Jokiranta , Zoltan Prohaszka
Molecular Immunology 67 ( 1) 189 -189

2015
The major autoantibody epitope on CFH and the structure of its homologous site on CFHR1 explain CFHR1 deficiency in autoimmune aHUS

Arnab Bhattacharjee , Stefanie Reuter , Eszter Trojnar , Robert Kolodziejczyk
MOLECULAR IMMUNOLOGY 61 ( 2) 231 -231

2014
Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder.

Barbara Uzonyi , Zsóka Szabó , Eszter Trojnár , Satu Hyvärinen
Frontiers in Immunology 12 660382 -660382

2021